PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable ® ’ disease targets, today announced it has relocated its headquarters to Unity Campus, a high ...

CAMBRIDGE, England-- (BUSINESS WIRE)--PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, today announced the introduction of GlueSEEKER™.

PhoreMost Ltd (PhoreMost) has entered into a research collaboration with the laboratory of Professor David Rubinsztein at the University of Cambridge. The groups will study and translate essential ...

PhoreMost Ltd., a next-generation targeted protein degradation (TPD) company progressing a pipeline of degrader therapeutics within oncology and inflammation, announces the appointment of Dr Adam ...

CAMBRIDGE, England-- (BUSINESS WIRE)--PhoreMost Ltd., has triggered a second milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim.

Neil Torbett is the CEO of PhoreMost, a biotechnology company based in Cambridge (UK) that is developing a pipeline of novel E3-ligase-based ‘next-generation’ degrader therapeutics. Our Assistant ...

PhoreMost Ltd (PhoreMost), a biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, has entered into a research collaboration with the laboratory of Professor David Rubinsztein ...

CAMBRIDGE, Mass., March 23, 2021 /PRNewswire/ -- XtalPi, an artificial intelligence (AI) drug discovery and development company, is pleased to announce its investment in the Series B financing of ...

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has made two appointments to strengthen its leadership team ...

PhoreMost will use the license to identify new targets in cancer and other diseases, then discover and develop small molecule cancer drugs designed to fight those targets. The resulting pipeline ...

DURHAM, N.C. and CAMBRIDGE, England, Jan. 5, 2022 /PRNewswire/ -- Polaris Quantum Biotech (POLARISqb), a NC-based quantum computing drug design company, and PhoreMost Limited, a UK-based ...